STAT3 and hematologic disorder: STAT3 has been shown to be overactivated in a variety of tumors (Epling-Burnette et al., 2001; Siddiquee et al., 2007; Bollrath et al., 2009; Chen and Zhang, 2017), including solid tumors and hematological malignancies.